Takanori Kitamura

Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells.

Hepatocyte growth factor activates endothelial nitric oxide synthase by Ca(2+)- and phosphoinositide 3-kinase/Akt-dependent phosphorylation in aortic endothelial cells.

Hepatocyte growth factor transduces different intracellular signals in aortic and umbilical venous endothelial cells.

Hepatocyte growth factor/scatter factor suppresses TNF-alpha-induced E-selectin expression in human umbilical vein endothelial cells.

Molecular cloning of canine membrane-anchored inhibitor of matrix metalloproteinase, RECK.

SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion.

Keeping out the bad guys: gateway to cellular target therapy.

Matrix metalloproteinase 7 is required for tumor formation, but dispensable for invasion and fibrosis in SMAD4-deficient intestinal adenocarcinomas.

Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling.

Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.

Education to promote verbal communication by caregivers in geriatric care facilities.

Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model.

Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling.

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.

Molecular mechanisms of liver metastasis.

Immune cell promotion of metastasis.

CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages.

Therapeutic potential of chemokine signal inhibition for metastatic breast cancer.

In vivo subcellular resolution optical imaging in the lung reveals early metastatic proliferation and motility.

Optical Windows for Imaging the Metastatic Tumour Microenvironment in vivo.

Targeting Tumor-Associated Macrophages as a Potential Strategy to Enhance the Response to Immune Checkpoint Inhibitors.

Macrophage targeting: opening new possibilities for cancer immunotherapy.

Targeting Macrophage-Recruiting Chemokines as a Novel Therapeutic Strategy to Prevent the Progression of Solid Tumors.